Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Stock Report

Mkt Cap: CN¥12.2b

Shanghai Yizhong Pharmaceutical Financial Health

Financial Health criteria checks 6/6

Shanghai Yizhong Pharmaceutical has a total shareholder equity of CN¥1.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥37.3M respectively. Shanghai Yizhong Pharmaceutical's EBIT is CN¥143.6M making its interest coverage ratio -4.5. It has cash and short-term investments of CN¥1.1B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-4.5x
CashCN¥1.09b
EquityCN¥1.38b
Total liabilitiesCN¥37.25m
Total assetsCN¥1.42b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688091's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥31.9M).

Long Term Liabilities: 688091's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥5.3M).


Debt to Equity History and Analysis

Debt Level: 688091 is debt free.

Reducing Debt: 688091 had no debt 5 years ago.

Debt Coverage: 688091 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688091 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies